Determination of the additional clinical value of contrast enhanced ultrasound imaging for the diagnosis of prostate cancer

Determination of the additional clinical value of contrast enhanced ultrasound imaging for the diagnosis of prostate cancer - Contrast enhanced ultrasound of the prostate

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON29721

Enrollment

200

Registered

2006-10-13

Start date

2006-09-26

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostate cancer prostate carcinoma

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Biopsy proven prostate carcinoma, treatment by (laparoscopic) radical prostatectomy

Exclusion criteria

Exclusion criteria: severe cardiac problems, severe hypertension

Design outcomes

Primary

Measure	Time frame
Parameters of contrast enhanced ultrasound will be correlated and compared to the histology of the resected prostate.	—

Secondary

Measure	Time frame
Adverse events of the used contrast agent	—

Countries

Netherlands

Outcome results